Form 8-K Sensei Biotherapeutics, For: Mar 27

Go back to Form 8-K Sensei Biotherapeutics, For: Mar 27

Sensei Biotherapeutics (SNSE) Announces CFO Resignation

April 2, 2024 7:50 AM EDT

On March 27, 2024, Erin Colgan notified Sensei Biotherapeutics (NASDAQ: SNSE) of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgans resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the... More